Stem Cell Sciences Ltd

Embryonic stem cell research

Stem Cell Sciences Limited (SCS) is an Australian biotechnology company founded in 1994 by Peter Mountford in order to commercialise achievements from the Institute for Stem Cell Research (ISCR) at the University of Edinburgh and Monash University, Melbourne. The company was founded on proprietary platform technologies allowing the isolation, growth and manipulation of stem cells. Since 2000 SCS functions as a group with operations in Australia, Scotland and Japan. SCS has entered licensing agreements with international biopharmaceutical companies, including Aventis, BioTransplant Inc., Genentech and Glaxo SmithKline.

Dr Alastair James Riddell, CEO
Hugh Ilyine, VP and COO
Timothy Allsopp, PhD, CSO

David Dodd, Chairman

Austin Smith, Prof., Chairman

Roger Land Building,
King’s Buildings
West Mains Road
Edinburgh
EH9 3JQ
UK
Phone: +44-(0)131-662-9829
Fax: +44-(0)131-662-9779

SCS is focused on technologies to grow, differentiate, select and purify embryonic stem cells. SCS owns a selection technology capable of purifying or enriching any cell type on the basis of any differentially expressed gene, to yield purified ES-derived cell cultures.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.